AR and posterior cortical atrophy: Although AR antagonists shown great benefits in treating PCa, drug resistances caused by AR mutation occur spontaneously in PCa6,7 as well as altered steroidogenesis8 underlies the emergence of castration-resistant prostate cancer (CRPC) within 2–3 years after starting ADT.